Theratechnologies Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript
Hello, everyone. Welcome to the H.C. Wainwright 5th Annual NASH Conference. For our next presentation, we have Dr. Christian Marsolais, Chief Medical Officer of Theratechnologies, a commercial stage company specializing in therapeutics of NASH, oncology and HIV. Dr. Marsolais, very good to have you with us. Please go ahead with your presentation.
Thank you very much, Thomas. Good afternoon, everyone. My name is Christian Marsolais, and I'm the Chief Medical Officer at Theratechnologies, and I will be presenting today the use of tesamorelin and for the treatment of NASH during this presentation. First, I would like to thank the H.C. Wainwright organization for inviting Theratechnologies to present our data at this 5th Annual NASH Investor Conference. I will give you a minute to read our forward-looking information.
I know that it has been a long day for you and I appreciate that you can sit with us for an additional 20 minutes just before Dr. Loomba starts
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |